NO20083249L - Imidazolderivater for behandling av gastrointestinale forstyrrelser - Google Patents
Imidazolderivater for behandling av gastrointestinale forstyrrelserInfo
- Publication number
- NO20083249L NO20083249L NO20083249A NO20083249A NO20083249L NO 20083249 L NO20083249 L NO 20083249L NO 20083249 A NO20083249 A NO 20083249A NO 20083249 A NO20083249 A NO 20083249A NO 20083249 L NO20083249 L NO 20083249L
- Authority
- NO
- Norway
- Prior art keywords
- treatment
- gastrointestinal disorders
- imidazole derivatives
- compounds
- gabab
- Prior art date
Links
- 208000018522 Gastrointestinal disease Diseases 0.000 title abstract 2
- 150000002460 imidazoles Chemical class 0.000 title abstract 2
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000002551 irritable bowel syndrome Diseases 0.000 abstract 2
- 239000000556 agonist Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 230000003281 allosteric effect Effects 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000000111 lower esophageal sphincter Anatomy 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000010992 reflux Methods 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 230000001052 transient effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0502906 | 2005-12-23 | ||
| PCT/SE2006/001462 WO2007073298A1 (en) | 2005-12-23 | 2006-12-21 | Imidazole derivatives for the treatment of gastrointestinal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083249L true NO20083249L (no) | 2008-07-23 |
Family
ID=38188929
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083249A NO20083249L (no) | 2005-12-23 | 2008-07-22 | Imidazolderivater for behandling av gastrointestinale forstyrrelser |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US7745474B2 (de) |
| EP (1) | EP1966154A4 (de) |
| JP (1) | JP2009521428A (de) |
| KR (1) | KR20080091452A (de) |
| CN (1) | CN101341130A (de) |
| AU (1) | AU2006327315A1 (de) |
| BR (1) | BRPI0620372A2 (de) |
| CA (1) | CA2632016A1 (de) |
| IL (1) | IL191750A0 (de) |
| NO (1) | NO20083249L (de) |
| WO (1) | WO2007073298A1 (de) |
| ZA (1) | ZA200805159B (de) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0401653D0 (sv) * | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| EP1966150A4 (de) * | 2005-12-23 | 2011-07-20 | Astrazeneca Ab | Pyrazole zur behandlung von gerd und ibs |
| BRPI0620372A2 (pt) | 2005-12-23 | 2011-11-08 | Astrazeneca Ab | composto, composição farmaceutica, e, uso de um composto |
| BRPI0620464A2 (pt) * | 2005-12-23 | 2011-11-16 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, método para o tratamento de uma doença |
| CN101341131A (zh) * | 2005-12-23 | 2009-01-07 | 阿斯利康(瑞典)有限公司 | 作为gaba-b受体调节剂的咪唑 |
| CN101374824A (zh) * | 2005-12-23 | 2009-02-25 | 阿斯利康(瑞典)有限公司 | 杂环gaba-b调节剂 |
| CN103403136A (zh) | 2011-01-04 | 2013-11-20 | 卢布里佐尔公司 | 具有延长防抖动耐久性的无级变速器流体 |
| TW201623257A (zh) | 2014-05-09 | 2016-07-01 | 奧利安公司 | 藥理活性之喹唑啉二酮衍生物 |
| GB202414200D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414197D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414199D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel Compounds |
| GB202414192D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
| GB202414193D0 (en) | 2024-09-27 | 2024-11-13 | Addex Pharmaceuticals Sa | Novel compounds |
Family Cites Families (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH449046A (de) | 1963-07-09 | 1967-12-31 | Ciba Geigy | Verfahren zur Herstellung neuer Aminosäuren |
| US3876655A (en) | 1971-08-18 | 1975-04-08 | Beecham Group Ltd | Anti-inflammatory acyl imidazoles |
| US4659720A (en) | 1982-12-20 | 1987-04-21 | Merck & Co., Inc. | 5-amino or substituted amino imidazoles useful to treat coccidiosis |
| GB8425872D0 (en) | 1984-10-12 | 1984-11-21 | Ciba Geigy Ag | Chemical compounds |
| GB8624879D0 (en) | 1986-10-17 | 1986-11-19 | May & Baker Ltd | Compositions of matter |
| GB8820266D0 (en) | 1988-08-26 | 1988-09-28 | Smith Kline French Lab | Compounds |
| GB8911017D0 (en) | 1989-05-13 | 1989-06-28 | Ciba Geigy Ag | Substituted aminoalkylphosphinic acids |
| FR2663934B1 (fr) | 1990-06-27 | 1994-06-03 | Adir | Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent. |
| US5214063A (en) | 1990-06-27 | 1993-05-25 | Adir Et Compagnie | 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors |
| DE4213750A1 (de) | 1992-04-25 | 1993-10-28 | Basf Ag | Verfahren zur Herstellung von 3-(Hydroxyphenyl)-propionaldehyden und gegebenenfalls der Herstellung von 3-(hydroxyphenyl)-propanolen |
| NZ262797A (en) | 1993-02-26 | 1997-08-22 | Schering Corp | Polycyclic guanine derivatives, purine and pyrimidine precursors; medicaments |
| FR2722192A1 (fr) | 1994-07-06 | 1996-01-12 | Adir | Nouveaux derives de l'acide 4-amino butyrique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| WO1997031900A1 (en) | 1996-02-29 | 1997-09-04 | Kissei Pharmaceutical Co., Ltd. | Imidazole derivatives and vascular wall thickening inhibitor |
| SE9603408D0 (sv) * | 1996-09-18 | 1996-09-18 | Astra Ab | Medical use |
| SE9904508D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| SE9904507D0 (sv) | 1999-12-09 | 1999-12-09 | Astra Ab | New compounds |
| WO2001090141A2 (en) | 2000-05-25 | 2001-11-29 | Merck Frosst Canada & Co. | Gb1c isoform and nucleotides |
| AU2001273040A1 (en) | 2000-06-27 | 2002-01-08 | Du Pont Pharmaceuticals Company | Factor xa inhibitors |
| EP1426366A4 (de) | 2001-09-14 | 2004-12-08 | Mitsubishi Pharma Corp | Thiazolidinderivate und deren medizinische verwendung |
| GB0209481D0 (en) | 2002-04-24 | 2002-06-05 | Novartis Ag | Organic compounds |
| SE0401653D0 (sv) | 2004-06-24 | 2004-06-24 | Astrazeneca Ab | New compounds |
| BRPI0620372A2 (pt) | 2005-12-23 | 2011-11-08 | Astrazeneca Ab | composto, composição farmaceutica, e, uso de um composto |
| CN101374824A (zh) | 2005-12-23 | 2009-02-25 | 阿斯利康(瑞典)有限公司 | 杂环gaba-b调节剂 |
| EP1966150A4 (de) | 2005-12-23 | 2011-07-20 | Astrazeneca Ab | Pyrazole zur behandlung von gerd und ibs |
| CN101341131A (zh) | 2005-12-23 | 2009-01-07 | 阿斯利康(瑞典)有限公司 | 作为gaba-b受体调节剂的咪唑 |
| BRPI0620464A2 (pt) | 2005-12-23 | 2011-11-16 | Astrazeneca Ab | composto, composição farmacêutica, uso de um composto, e, método para o tratamento de uma doença |
| US20080262064A1 (en) | 2007-04-18 | 2008-10-23 | Astrazeneca Ab | Novel Compounds For The Treatment Of GI Disorders 682 |
| MX2009010893A (es) | 2007-04-18 | 2009-10-26 | Astrazeneca Ab | Compuestos de xantina que tienen un efecto modulador del receptor gabab alosterico positivo. |
-
2006
- 2006-12-21 BR BRPI0620372-8A patent/BRPI0620372A2/pt not_active IP Right Cessation
- 2006-12-21 EP EP06824532A patent/EP1966154A4/de not_active Withdrawn
- 2006-12-21 JP JP2008547165A patent/JP2009521428A/ja active Pending
- 2006-12-21 WO PCT/SE2006/001462 patent/WO2007073298A1/en not_active Ceased
- 2006-12-21 US US12/158,167 patent/US7745474B2/en not_active Expired - Fee Related
- 2006-12-21 KR KR1020087018001A patent/KR20080091452A/ko not_active Withdrawn
- 2006-12-21 CA CA002632016A patent/CA2632016A1/en not_active Abandoned
- 2006-12-21 AU AU2006327315A patent/AU2006327315A1/en not_active Abandoned
- 2006-12-21 CN CNA2006800482794A patent/CN101341130A/zh active Pending
-
2008
- 2008-05-27 IL IL191750A patent/IL191750A0/en unknown
- 2008-06-12 ZA ZA200805159A patent/ZA200805159B/xx unknown
- 2008-07-22 NO NO20083249A patent/NO20083249L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2632016A1 (en) | 2007-06-28 |
| EP1966154A1 (de) | 2008-09-10 |
| US20090005428A1 (en) | 2009-01-01 |
| US7745474B2 (en) | 2010-06-29 |
| CN101341130A (zh) | 2009-01-07 |
| AU2006327315A1 (en) | 2007-06-28 |
| KR20080091452A (ko) | 2008-10-13 |
| ZA200805159B (en) | 2009-03-25 |
| JP2009521428A (ja) | 2009-06-04 |
| EP1966154A4 (de) | 2011-01-26 |
| BRPI0620372A2 (pt) | 2011-11-08 |
| WO2007073298A1 (en) | 2007-06-28 |
| IL191750A0 (en) | 2008-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083248L (no) | Imidazoler som GABA-B reseptormodulatorer | |
| NO20083247L (no) | GABA-B reseptormodulatorer | |
| NO20083243L (no) | Pyrazoler for behandling av GERD og IBS | |
| NO20083244L (no) | Heterosykliske GABA-B modulatorer | |
| EA201101334A1 (ru) | Новые соединения бензотиадиазепина, способ их приготовления и фармацевтические композиции, содержащие их | |
| SE0401653D0 (sv) | New compounds | |
| MX2009010893A (es) | Compuestos de xantina que tienen un efecto modulador del receptor gabab alosterico positivo. | |
| AR078163A1 (es) | Utilizacion de aminodihidrotiazinas para el tratamiento o prevencion de la diabetes | |
| NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
| NO20085385L (no) | Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav | |
| EA201101089A1 (ru) | Производные оксадиазола в качестве агонистов рецептора s1p1 | |
| EA201270646A1 (ru) | Ингибиторы глюкозилцерамидсинтазы | |
| NO20083057L (no) | Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer | |
| SMT201300085B (it) | Composti di pirrolo | |
| NO20063599L (no) | Ytterligere heterosykliske forbindelser og deres anvendelse som metabotrofiske glutamatreseptorantagonister | |
| NO20083717L (no) | Pyrrolotriazin-anilin prodrugforbindelser anvendbare som kinaseinhibitorer | |
| EA201000947A1 (ru) | Производные тиазола, применимые в качестве ингибиторов киназы pi3 | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| NO20082934L (no) | Antivirale nukleotider | |
| WO2009156861A3 (en) | Substituted pyrimidone derivatives | |
| EA200971044A1 (ru) | Арил- и гетероарилзамещенные тетрагидробензо-1,4-диазепины и их применение для блокирования обратного захвата норэпинефрина, допамина и серотонина | |
| NO20063621L (no) | Derivater av N-`(1,5-difenyl-1H-pyrazol-3-yl) sulfonamid med CB1 receptoraffinitet | |
| EA201170722A1 (ru) | Лактамы в качестве ингибиторов бета-секретазы | |
| EA201071012A1 (ru) | Производные азетидинов, способ их получения и применение их в терапии | |
| JO2673B1 (en) | New diosmetin compounds, a process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |